Related Experiment Video
Updated: Jun 18, 2026
15:43
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Airway inflammation in chronic obstructive pulmonary disease
Katarzyna Górska1, Marta Maskey-Warzechowska, Rafał Krenke
1Department of Internal Medicine, Pneumonology and Allergology, Medical University of Warsaw, Warsaw, Poland. kpgorska@wp.pl
Current Opinion in Pulmonary Medicine
|November 12, 2009
Summary
Chronic obstructive pulmonary disease (COPD) involves complex airway inflammation. Recent research highlights eosinophils and new cytokines, suggesting distinct patient phenotypes and novel therapeutic targets for COPD.
Area of Science:
- Pulmonary Medicine
- Immunology
- Respiratory Research
Background:
- Chronic obstructive pulmonary disease (COPD) is characterized by chronic airway inflammation.
- Understanding inflammatory pathways is crucial for developing new COPD therapies.
- Key inflammatory cells and mediators in COPD pathogenesis are known, but their interactions remain unclear.
Purpose of the Study:
- To explore novel theories on the inflammatory pathways in COPD.
- To investigate the role of various factors, including cigarette smoke and other triggers, in airway inflammation.
- To identify new therapeutic strategies based on a deeper understanding of COPD pathogenesis.
Main Methods:
- Review of recent studies on COPD inflammation.
- Analysis of inflammatory cell involvement, including neutrophils, macrophages, and eosinophils.
- Identification of novel cytokines and their role in COPD.
Main Results:
- Evidence suggests eosinophils play a significant role in COPD pathogenesis, potentially defining a distinct phenotype with therapeutic implications.
- New cytokines, such as interleukin 32, have been identified as involved in COPD.
- Inflammation in upper airways has been observed in COPD patients.
- The relationship between inflammatory cell numbers and activity in COPD is complex.
Conclusions:
- Significant questions remain regarding the pathogenesis of COPD.
- Recent findings offer a new perspective on airway inflammation in COPD.
- Current research points towards promising new directions for COPD investigation and treatment.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.